Clinical features of anemia in membranous nephropathy patients: a Chinese cohort study

References

• Lankhorst CE, Wish JB. Anemia in renal disease: diagnosis and management. Blood Rev. 2010;24(1):39–47.
   PubMed Web of Science ®Google Scholar
• Babitt JL, Lin HY. Mechanisms of anemia in CKD. J Am Soc Nephrol. 2012;23(10):1631–1634.
   PubMed Web of Science ®Google Scholar
• Thorp ML, Johnson ES, Yang X, et al. Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease. Nephrology. 2009;14(2):240–246.
   PubMed Web of Science ®Google Scholar
• De NL, Minutolo R, Chiodini P, et al. Prevalence and prognosis of mild anemia in non-dialysis chronic kidney disease: a prospective cohort study in outpatient renal clinics. Am J Nephrol. 2010;32(6):533–540.
   PubMed Web of Science ®Google Scholar
• Matsumura K, Okumiya T, Sugiura T, et al. Shortened red blood cell age in patients with end-stage renal disease who were receiving haemodialysis: a cross-sectional study. BMC Nephrol. 2020;21(1):418.
   PubMed Web of Science ®Google Scholar
• Philip KTL, Agnes SMC, Sunita B, et al. Anemia management in peritoneal dialysis: perspectives from the Asia Pacific region. Kidney Med. 2021;3(3):405–411.
   PubMedGoogle Scholar
• Hoshino J, Muenz D, Zee J, CKDopps Investigators, et al. Associations of hemoglobin levels with health-related quality of life, physical activity, and clinical outcomes in persons with stage 3-5 nondialysis CKD. J Ren Nutr. 2020;30(5):404–414.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wei RB, Su TY, et al. Clinical and pathological factors of renal anaemia in patients with IgA nephropathy in Chinese adults: a cross-sectional study. BMJ Open. 2019;9(1):e023479.
   PubMed Web of Science ®Google Scholar
• Idris I, Tohid H, Muhammad NA, et al. Anaemia among primary care patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD): a multicentred cross-sectional study. BMJ Open. 2018;8(12):e025125.
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline Working Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int. 2012;Suppl 2(4):279–335.
   Google Scholar
• Lopez A, Cacoub P, Macdougall IC, et al. Iron deficiency anaemia. Lancet. 2016;387(10021):907–916.
   PubMed Web of Science ®Google Scholar
• DeLoughery TG. Microcytic anemia. N Engl J Med. 2014;371(14):1324–1331.
   PubMed Web of Science ®Google Scholar
• Matsushita K, Mahmoodi BK, Woodward M, Chronic Kidney Disease Prognosis Consortium, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA. 2012;307(18):1941–1951.
   PubMed Web of Science ®Google Scholar
• Coresh J, Turin TC, Matsushita K, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311(24):2518–2531.
   PubMed Web of Science ®Google Scholar
• Li Y, Shi H, Wang WM, et al. Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: first multicenter, cross-sectional study. Medicine. 2016;95(24):e3872.
   PubMed Web of Science ®Google Scholar
• Yue H, Zhou P, Xu Z, et al. Effect of low-protein diet on kidney function and nutrition in nephropathy: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr. 2020;39(9):2675–2685.
   PubMed Web of Science ®Google Scholar
• Xiong J, Wang M, Zhang Y, et al. Association of geriatric nutritional risk index with mortality in hemodialysis patients: a meta-analysis of cohort studies. Kidney Blood Press Res. 2018;43(6):1878–1889.
   PubMed Web of Science ®Google Scholar
• Zuo K, Wu Y, Li SJ, et al. Long-term outcome and prognostic factors of idiopathic membranous nephropathy in the Chinese population. Clin Nephrol. 2013;79(6):445–453.
   PubMed Web of Science ®Google Scholar
• Zhang XD, Cui Z, Zhang MF, et al. Clinical implications of pathological features of primary membranous nephropathy. BMC Nephrol. 2018;19(1):215.
   PubMedGoogle Scholar
• Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009;4(2):481–508.
   PubMed Web of Science ®Google Scholar
• Vlahakos DV, Tsioufis C, Manolis A, et al. Inhibition of the renin-angiotensin system in the cardiorenal syndrome with anaemia: a double-edged sword. J Hypertens. 2019;37(11):2145–2153.
   PubMed Web of Science ®Google Scholar
• Bamgbola OF, Kaskel F. Role of folate deficiency on erythropoietin resistance in pediatric and adolescent patients on chronic dialysis. Pediatr Nephrol. 2005;20(11):1622–1629.
   PubMed Web of Science ®Google Scholar
• Tkaczyszyn M, Comín-Colet J, Voors AA, et al. Iron deficiency contributes to resistance to endogenous erythropoietin in anaemic heart failure patients. Eur J Heart Fail. 2021;23(10):1677–1686.
   PubMed Web of Science ®Google Scholar
• Giliberti A, Curcio A, Marchitto N, et al. Comparison of ferric sodium EDTA in combination with vitamin C, folic acid, copper gluconate, zinc gluconate, and selenomethionine as therapeutic option for chronic kidney disease patients with improvement in inflammatory status. Nutrients. 2022;14(10):2116.
   PubMed Web of Science ®Google Scholar
• Matsumoto AK, Michelin AP, Semeão LO, et al. A randomized trial of short-term treatment with folic acid to reduce the oxidative stress of patients with chronic kidney disease. Curr Drug Metab. 2021;22(14):1139–1150.
   PubMed Web of Science ®Google Scholar
• Singh AK, Szczech L, Tang KL, CHOIR Investigators, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355(20):2085–2098.
   PubMed Web of Science ®Google Scholar
• Pfeffer MA, Burdmann EA, Chen CY, TREAT Investigators, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009;361(21):2019–2032.
   PubMed Web of Science ®Google Scholar
• Besarab A, Bolton WK, Browne JK, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339(9):584–590.
   PubMed Web of Science ®Google Scholar